Paper1990253
Efficacy of postoperative chemotherapy using cisplatin plus etoposide in young children with brain tumors.
Strauss LC and 5 others. Med Pediatr Oncol, 1991. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Efficacy of postoperative chemotherapy using cisplatin plus etoposide in young children with brain tumors. Papers, record 1990253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1990253
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy of postoperative chemotherapy using cisplatin plus etoposide in young children with brain tumors.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Brain Neoplasms | Major topic |
| Cisplatin | Major topic |
| Etoposide | Major topic |
| Child, Preschool | |
| Combined Modality Therapy | |
| Female | |
| Humans | |
| Infant | |
| Male | |
| Pilot Projects | |
| Tomography, X-Ray Computed |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 20976614 | Which therapy works better in choroid plexus carcinomas? | J Neurooncol | 2011 | https://conductscience.org/library/papers/20976614 | PubMed |
| 11580310 | Pharmacotherapy of malignant astrocytomas of children and adults: current strategies and future trends. | CNS Drugs | 2001 | https://conductscience.org/library/papers/11580310 | PubMed |
| 8832463 | Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy. | J Neurooncol | 1996 | https://conductscience.org/library/papers/8832463 | PubMed |
| 8787426 | An intensive multiagent chemotherapy regimen for brain tumours occurring in very young children. | Arch Dis Child | 1996 | https://conductscience.org/library/papers/8787426 | PubMed |
| 8556723 | Preoperative chemotherapy with carboplatin alone in high risk medulloblastoma. | Childs Nerv Syst | 1995 | https://conductscience.org/library/papers/8556723 | PubMed |
| 8397068 | Preirradiation chemotherapy for very young children with brain tumors. | Childs Nerv Syst | 1993 | https://conductscience.org/library/papers/8397068 | PubMed |
| 8339393 | Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours. A report from the Australia and New Zealand Childhood Cancer Study Group (ANZCCSG). | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8339393 | PubMed |
| 7954494 | Preirradiation chemotherapy. | Childs Nerv Syst | 1994 | https://conductscience.org/library/papers/7954494 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1990253
GET https://conductscience.org/api/papers/v1/1990253/authors